The role of CD4+ or CD8+ T cells in the protective immune response of BALB/c mice to Neospora caninum infection

被引:51
作者
Tanaka, T [1 ]
Hamada, T [1 ]
Inoue, N [1 ]
Nagasawa, H [1 ]
Fujisaki, K [1 ]
Suzuki, N [1 ]
Mikami, T [1 ]
机构
[1] Obihiro Univ Agr & Vet Med, Res Ctr Protozoan Mol Immunol, Obihiro, Hokkaido 0808555, Japan
关键词
Neospora caninum; T cell; CD4(+); CD8(+); IFN-gamma; antibody;
D O I
10.1016/S0304-4017(00)00238-7
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
The role of CD4(+) or CD8(+) T cells in the immune response of BALB/c mice against Neospora caninum infection was examined by using anti-CD4 and/or anti-CD8 monoclonal antibodies (mAbs). Mice were intraperitoneally inoculated with anti-CD4, and/or anti-CD8 mAbs before and after infection with N. caninum and observed for 30 days after infection. Most of the anti-CD4 mAb-treated mice and all of the anti-CD4 and anti-CD8 mAbs-treated mice died within 30 days post-infection (p.i.). In contrast, 100% of PBS-treated mice and 70% of anti-CD8 mAb-treated mice survived more than 30 days. When compared with phosphate-buffered saline (PBS)-treated mice, the weight of mice treated with mAbs tended to decrease. From these results CD4(+) T cells, but not CD8(+) T cells, have an important role for protection of mice against N. caninum infection. Serum antibody levels to N. caninum in infected-mice treated with anti-CD4 mAb or a mixture of anti-CD4 and anti-CDS mAbs were lower than those in the infected mice treated with anti-CD8 mAb or PBS. The mice treated with anti-interferon-gamma (IFN-gamma) mAb produced high antibody levels to N. caninum, but all mice died within 18 days p.i. These results indicated that IFN-gamma is an important cytokine for protection against N. caninum infection at the early stage of infection. However, since CD4(+) T cells against N. caninum were essential to the production of specific antibody, these antibodies might have important roles in host protection at the later stage of infection. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:183 / 191
页数:9
相关论文
共 14 条
[1]   Canine neosporosis: clinical signs, diagnosis, treatment and isolation of Neospora caninum in mice and cell culture [J].
Dubey, JP ;
Dorough, KR ;
Jenkins, MC ;
Liddell, S ;
Speer, CA ;
Kwok, OCH ;
Shen, SK .
INTERNATIONAL JOURNAL FOR PARASITOLOGY, 1998, 28 (08) :1293-1304
[2]  
Eperon S, 1999, PARASITE IMMUNOL, V21, P225, DOI 10.1046/j.1365-3024.1999.00223.x
[3]   INTERFERON-GAMMA INHIBITS THE INTRACELLULAR MULTIPLICATION OF NEOSPORA-CANINUM, AS SHOWN BY INCORPORATION OF H-3 URACIL [J].
INNES, EA ;
PANTON, WRM ;
MARKS, J ;
TREES, AJ ;
HOLMDAHL, J ;
BUXTON, D .
JOURNAL OF COMPARATIVE PATHOLOGY, 1995, 113 (01) :95-100
[4]   Interleukin 4 is a crucial cytokine in controlling Trypanosoma brucei gambiense infection in mice [J].
Inoue, N ;
Inoue, M ;
Kuriki, K ;
Yamaguchi, H ;
Nagasawa, H ;
Mikami, T ;
Fujisaki, K ;
Suzuki, N ;
Hirumi, H .
VETERINARY PARASITOLOGY, 1999, 86 (03) :173-184
[5]   Antigen-specific CD8+ T cells protect against lethal toxoplasmosis in mice infected with Neospora caninum [J].
Kasper, LH ;
Khan, IA .
INFECTION AND IMMUNITY, 1998, 66 (04) :1554-1560
[6]   Neospora caninum: Role for immune cytokines in host immunity [J].
Khan, IA ;
Schwartzman, JD ;
Fonseka, S ;
Kasper, LH .
EXPERIMENTAL PARASITOLOGY, 1997, 85 (01) :24-34
[7]   XENOGENEIC MONOCLONAL ANTIBODIES TO MOUSE LYMPHOID DIFFERENTIATION ANTIGENS [J].
LEDBETTER, JA ;
HERZENBERG, LA .
IMMUNOLOGICAL REVIEWS, 1979, 47 :63-90
[8]   MOUSE MODEL FOR CENTRAL-NERVOUS-SYSTEM NEOSPORA-CANINUM INFECTIONS [J].
LINDSAY, DS ;
LENZ, SD ;
COLE, RA ;
DUBEY, JP ;
BLAGBURN, BL .
JOURNAL OF PARASITOLOGY, 1995, 81 (02) :313-315
[9]   Dogs are definitive hosts of Neospora caninum [J].
McAllister, MM ;
Dubey, JP ;
Lindsay, DS ;
Jolley, WR ;
Wills, RA ;
McGuire, AM .
INTERNATIONAL JOURNAL FOR PARASITOLOGY, 1998, 28 (09) :1473-1478
[10]   CD8+ T-CELLS ARE THE MAJOR LYMPHOCYTE SUBPOPULATION INVOLVED IN THE PROTECTIVE IMMUNE-RESPONSE TO TOXOPLASMA-GONDII IN MICE [J].
PARKER, SJ ;
ROBERTS, CW ;
ALEXANDER, J .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1991, 84 (02) :207-212